{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:26:27Z","timestamp":1783837587701,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025475","name":"Energy Networks Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006255","name":"Universidad de Concepcion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jgar.2025.05.016","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:56:25Z","timestamp":1747968985000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Genomic characterisation of the first case of IMP-13-producing carbapenem-resistant Pseudomonas aeruginosa ST313\/ExoU+\/O1 isolate in Chile"],"prefix":"10.1016","volume":"44","author":[{"given":"Maximiliano","family":"Matus-K\u00f6hler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Araya-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aguayo-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Quezada-Aguiluz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-4998","authenticated-orcid":false,"given":"N\u00e9stor","family":"Herrera-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-2844","authenticated-orcid":false,"given":"Felipe","family":"Morales-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-1236","authenticated-orcid":false,"given":"Gerardo","family":"Gonz\u00e1lez-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-7625","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Opazo-Capurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.05.016_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2024.05.015","article-title":"Genomic and phylogenomic characterization of carbapenem-resistant Pseudomonas aeruginosa \u201chigh-risk\u201d clone O4\/ExoS+\/ST654 circulating in Chilean hospitals","author":"Opazo-Capurro","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2025.05.016_bib0002","unstructured":"WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024."},{"key":"10.1016\/j.jgar.2025.05.016_bib0003","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","article-title":"Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study","volume":"4","author":"Reyes","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2025.05.016_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jgar.2024.07.003","article-title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant","volume":"38","author":"Zurita","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2025.05.016_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.614058","article-title":"Mobile carbapenemase genes in Pseudomonas aeruginosa","volume":"12","author":"Yoon","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.05.016_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","volume":"21\u201322","author":"Oliver","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jgar.2025.05.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2025.05.016_bib0008","unstructured":"Clinical and Laboratory Standards Institute (CLSI) USA. Performance Standards for Antimicrobial Susceptibility Testing. 33rd Ed. CLSI supplement M100 (ISBN 978-1-68440-170-3 [Print]; ISBN 978-1-68-440-171-0 [Electronic]. Clinical and Laboratory Standards Institute, USA, 2023."},{"key":"10.1016\/j.jgar.2025.05.016_bib0009","first-page":"13","article-title":"The PLSDB 2025 update: enhanced annotations and improved functionality for comprehensive plasmid research","volume":"1","author":"Molano","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgar.2025.05.016_bib0010","article-title":"Coexistence of tmexCD3-toprJ1b tigecycline resistance genes with two novel blaVIM-2-carrying and blaOXA-10-carrying transposons in a Pseudomonas asiatica plasmid","volume":"13","author":"Li","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2025.05.016_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01066-21","article-title":"Characterization of the first carbapenem-resistant Pseudomonas aeruginosa clinical isolate harboring blaSIM-1 from the United States","volume":"65","author":"Prussing","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.05.016_bib0012","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/antibiotics13020191","article-title":"Molecular analysis of carbapenem and aminoglycoside resistance genes in carbapenem-resistant Pseudomonas aeruginosa clinical strains: a challenge for tertiary care hospitals","volume":"13","author":"Gondal","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.05.016_bib0013","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.resmic.2007.12.008","article-title":"Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary","volume":"159","author":"Libisch","year":"2008","journal-title":"Res Microbiol"},{"key":"10.1016\/j.jgar.2025.05.016_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02283-22","article-title":"Emergence of an extensive drug resistant Pseudomonas aeruginosa strain of chicken origin carrying blaIMP-45, tet (X6), and tmexCD3 - toprJ3 on an Inc pRBL16 Plasmid","volume":"10","author":"Dong","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2025.05.016_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmi.2017.12.016","article-title":"Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene\u2013based approaches","volume":"24","author":"Sch\u00fcrch","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:18:34Z","timestamp":1777101514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":15,"alternative-id":["S2213716525001201"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.05.016","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic characterisation of the first case of IMP-13-producing carbapenem-resistant Pseudomonas aeruginosa ST313\/ExoU+\/O1 isolate in Chile","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}